← Back to Screener
Alvotech Ordinary Shares (ALVO)
Price$3.22
Value ScoreC
Growth ScoreB
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-49.53%
Price vs S&P 500 (4W)-7.86%
VGM Score49.07
Market Capitalization$1.05B
P/E Ratio (Annual)37.55x
All Metrics
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)90.62%
Cash Flow / Share (Quarterly)$-0.47
Price vs S&P 500 (YTD)-45.44%
Gross Margin (TTM)60.00%
Net Profit Margin (TTM)4.74%
EPS (TTM)$0.07
10-Day Avg Trading Volume0.45M
EPS Excl Extra (TTM)$0.07
Revenue Growth (5Y)53.35%
EPS (Annual)$0.10
Gross Margin (Annual)60.00%
Net Profit Margin (5Y Avg)-298.62%
Cash / Share (Quarterly)$0.55
P/E Basic Excl Extra (TTM)37.55x
Revenue Growth QoQ (YoY)10.14%
P/E Normalized (Annual)37.55x
ROA (Last FY)1.88%
Revenue Growth TTM (YoY)19.70%
EBITD / Share (TTM)$0.48
Operating Margin (TTM)17.64%
Cash Flow / Share (Annual)$-0.47
Net Income / Employee (Annual)$19,100
EV / Revenue (TTM)3.95x
Net Interest Coverage (TTM)-0.02x
ROA (TTM)2.02%
EV / EBITDA (TTM)16.41x
EPS Incl Extra (Annual)$0.10
Current Ratio (Annual)1.89x
Quick Ratio (Quarterly)1.07x
3-Month Avg Trading Volume0.50M
52-Week Price Return-69.84%
P/E Incl Extra (TTM)37.55x
Revenue / Employee (TTM)$403,400
P/S Ratio (Annual)1.78x
Asset Turnover (Annual)0.40x
52-Week High$11.85
Operating Margin (5Y Avg)-207.16%
EPS Excl Extra (Annual)$0.10
CapEx CAGR (5Y)51.66%
26-Week Price Return-33.60%
Quick Ratio (Annual)1.07x
13-Week Price Return-19.23%
Current Ratio (Quarterly)1.89x
Enterprise Value$2.33B
Revenue / Share Growth (5Y)-1.77%
Asset Turnover (TTM)0.43x
Revenue / Employee (Annual)$403,400
Inventory Turnover (Annual)1.35x
Pretax Margin (Annual)23.15%
Cash / Share (Annual)$0.55
3-Month Return Std Dev64.55%
Net Income / Employee (TTM)$19,100
Net Interest Coverage (Annual)1.85x
EPS Basic Excl Extra (Annual)$0.10
Receivables Turnover (TTM)3.26x
EPS Incl Extra (TTM)$0.07
Receivables Turnover (Annual)3.26x
P/S Ratio (TTM)1.78x
Pretax Margin (5Y Avg)-348.62%
Revenue / Share (Annual)$2.03
Forward P/E22.83x
Price vs S&P 500 (52W)-98.04%
P/E Ratio (TTM)37.55x
Year-to-Date Return-34.50%
5-Day Price Return0.60%
EPS Normalized (Annual)$0.10
ROA (5Y Avg)-30.83%
Net Profit Margin (Annual)4.74%
Month-to-Date Return0.60%
EBITD / Share (Annual)$0.41
Operating Margin (Annual)17.64%
P/E Excl Extra (TTM)37.55x
EPS Basic Excl Extra (TTM)$0.07
Inventory Turnover (TTM)1.35x
Pretax Margin (TTM)23.15%
Price vs S&P 500 (13W)-28.98%
Beta0.22x
Revenue / Share (TTM)$2.05
52-Week Low$3.03
vGradeC
gGradeB
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q1 260.00est. 0.02
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.92
3.92
3.92
3.92
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ALVOAlvotech Ordinary Shares | C | B | D | $3.22 |
| AMGNAmgen Inc | C | C | C | $329.13 |
| GILDGilead Sciences Inc | C | B | C | $131.10 |
| ARGXargenx SE American Depositary Shares | D | A | C | $836.09 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $163.68 |
| BIIBBiogen Inc. Common Stock | B | D | B | $192.23 |
| BNTXBioNTech SE American Depositary Share | C | C | C | $91.70 |
| MRNAModerna, Inc. Common Stock | C | B | B | $46.06 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $161.00 |
| EXELExelixis Inc | C | B | B | $50.28 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | B | $298.10 |
About
Alvotech is an integrated biopharmaceutical company that develops and manufactures biosimilar medicines. The company creates affordable alternatives to existing biologic therapies, expanding patient access to treatments while leveraging its integrated research, development, and manufacturing capabilities.